HCA Healthcare Q3 EPS Estimate Increased by Leerink Partnrs

HCA Healthcare, Inc. (NYSE:HCA) – Equities researchers at Leerink Partnrs raised their Q3 2025 EPS estimates for HCA Healthcare in a report released on Sunday, July 27th. Leerink Partnrs analyst W. Mayo now anticipates that the company will post earnings of $5.99 per share for the quarter, up from their prior estimate of $5.84. The consensus estimate for HCA Healthcare’s current full-year earnings is $24.98 per share. Leerink Partnrs also issued estimates for HCA Healthcare’s FY2025 earnings at $26.81 EPS and FY2029 earnings at $41.22 EPS.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating analysts’ consensus estimates of $6.20 by $0.64. The business had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. HCA Healthcare’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter last year, the business posted $5.50 earnings per share.

A number of other analysts have also commented on the stock. Morgan Stanley lowered their target price on shares of HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating for the company in a report on Monday. Wall Street Zen raised shares of HCA Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, July 5th. Stephens raised shares of HCA Healthcare to a “strong-buy” rating in a research report on Monday, June 2nd. Truist Financial lifted their price target on shares of HCA Healthcare from $390.00 to $415.00 and gave the stock a “buy” rating in a research report on Wednesday, July 16th. Finally, Baird R W cut shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, April 15th. Nine analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $396.46.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $355.16 on Tuesday. The company has a debt-to-equity ratio of 69.07, a current ratio of 0.98 and a quick ratio of 0.86. The firm has a market cap of $85.44 billion, a P/E ratio of 14.93, a P/E/G ratio of 1.08 and a beta of 1.47. The firm has a 50 day simple moving average of $371.51 and a 200 day simple moving average of $346.46. HCA Healthcare has a fifty-two week low of $289.98 and a fifty-two week high of $417.14.

Hedge Funds Weigh In On HCA Healthcare

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Sanders Capital LLC raised its stake in shares of HCA Healthcare by 1.0% during the fourth quarter. Sanders Capital LLC now owns 11,655,563 shares of the company’s stock valued at $3,498,417,000 after acquiring an additional 116,826 shares during the last quarter. Geode Capital Management LLC increased its position in shares of HCA Healthcare by 1.3% during the fourth quarter. Geode Capital Management LLC now owns 3,871,057 shares of the company’s stock worth $1,159,882,000 after buying an additional 50,321 shares during the period. Capital World Investors increased its position in shares of HCA Healthcare by 0.7% during the fourth quarter. Capital World Investors now owns 2,928,452 shares of the company’s stock worth $878,975,000 after buying an additional 19,121 shares during the period. Price T Rowe Associates Inc. MD increased its position in shares of HCA Healthcare by 83.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock worth $829,104,000 after buying an additional 1,091,416 shares during the period. Finally, Northern Trust Corp increased its position in shares of HCA Healthcare by 12.4% during the fourth quarter. Northern Trust Corp now owns 2,017,971 shares of the company’s stock worth $605,694,000 after buying an additional 223,248 shares during the period. Institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling

In related news, COO Jon M. Foster sold 15,698 shares of the stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the transaction, the chief operating officer owned 12,646 shares of the company’s stock, valued at $4,670,420.72. This represents a 55.38% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.30% of the stock is currently owned by insiders.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be paid a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.81%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare’s payout ratio is 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.